Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8306 ↗At a glance
Journal article in Phytotherapy Research, 2024. Written by Yawei Zheng and 10 co-authors. Institution: Nanjing University of Chinese Medicine, Nanjing, China. Major MEDLINE topics: Quercetin, Hypertension, Dietary Supplements. Cited 12 times so far (Crossref); 36 references. Funded by: Projects of Jiangsu Chinese Medicine Clinical Medicine Innovation Center for Hypertension, National Natural Science Foundation of China, Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (original language)
Quercetin has shown potential antihypertensive‐like activities in several studies. The present study aimed to test the effect of quercetin supplementation on kidney damage and long‐term prognosis in hypertensive patients. The data of enrolled hypertensive patients were acquired from the NHANES dataset. The flavanol intake data was extracted from the FNDDS flavonoid database. Information regarding mortality was extracted from the NCHS. A total of 5801 hypertensive patients were included in this study. Preliminary analysis found that the total flavanols intake dosage was the independent influence factor of the kidney damage prevalence in hypertension, and it was found that only the quercetin supplementation was the protective factor for kidney damage after stratification analysis. For every 10 mg/d increase in quercetin intake, the kidney damage prevalence decreased by 8% [OR = 0.92, 95% CI: 0.85–0.99, p = 0.032]. The comprehensive analysis results suggested that hypertensive patients in the quercetin‐high group had a lower kidney damage prevalence and a higher survival probability than those in the quercetin‐low group. The urine microalbumin of hypertensive patients in the quercetin‐high group was significantly lower than that of hypertensive patients in the quercetin‐low group. In addition, at a median follow‐up time of 122 months, the mortality decreased by 9% [HR = 0.91, 95% CI: 0.84–0.99, p = 0.031] for every 10 mg/d increase in quercetin intake. The findings suggested that high quercetin intake was associated with low kidney damage prevalence and high survival probability. Based on the existing evidence, promoting quercetin supplementation as a supplementary treatment for hypertensive patients was warranted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Nanjing University of Chinese Medicine, Nanjing, China.
- Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
ORCID profiles: Yawei Zheng
Funding
- Projects of Jiangsu Chinese Medicine Clinical Medicine Innovation Center for Hypertension
- National Natural Science Foundation of China
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- The First session of Excellent Young Doctor Training Program of Jiangsu Provincial Hospital of Chinese Medicine
Cite
APA
Zheng, Y., Fang, Y., Li, L., Wang, H., Zhang, S., Zhu, Y., Wang, Y., Meng, X., Fang, Z., Luo, Y., & Fang, Z. (2024). Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients. Phytotherapy Research. https://doi.org/10.1002/ptr.8306
Vancouver
Zheng Y, Fang Y, Li L, Wang H, Zhang S, Zhu Y, et al. Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients. Phytotherapy Research. 2024. doi:10.1002/ptr.8306
BibTeX
@article{Zheng2024,
author = {Zheng, Yawei and Fang, Yuan and Li, Li and Wang, Huihui and Zhang, Siqi and Zhu, Yuan and Wang, Yating and Meng, Xianze and Fang, Zhen and Luo, Yu and Fang, Zhuyuan},
title = {Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8306}
}
EUVIMED